%PDF-1.4
%
33 0 obj
<>
endobj
30 0 obj
<>
endobj
86 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-09T15:54:47Z
2024-03-28T06:46:59-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-28T06:46:59-07:00
application/pdf
Heather
2001-428.july
uuid:26e438fd-1dd2-11b2-0a00-730927bd7700
uuid:26e438ff-1dd2-11b2-0a00-900000000000
endstream
endobj
19 0 obj
<>
endobj
20 0 obj
<>
endobj
34 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
12 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
15 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
104 0 obj
[108 0 R]
endobj
105 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
/CS0 CS 0 0 0 1 SCN
/GS1 gs
54 54 m
558 54 l
S
BT
/CS0 cs 0 0 0 1 scn
/TT0 1 Tf
0.02499 Tw 8 0 0 8 424.3613 35.9844 Tm
(The Journal of Rheumatology 2002; 29:7)Tj
0 Tw -46.2952 -0.0313 Td
(1392)Tj
ET
0 0 0 0 scn
/GS0 gs
102.17 58.87 407.5 -10.84 re
f*
0.5 w
102.17 58.87 407.5 -10.84 re
S
BT
0 0 0 1 scn
/GS1 gs
/TT1 1 Tf
0.02499 Tw 8 0 0 8 74.4 714.5293 Tm
(infarction. Circulation 1981;64:235-42.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(10.)-875.1 (Breithardt G, Cain ME, El-Sherif N, et al. Standards for analysis of)]TJ
0 Tc 2.175 -1.25 Td
(ventricular late potentials using high-resolution or signal-averaged)Tj
0 -1.25 TD
[(electrocardiography)64.9 (. J )54.8 (Am Coll Cardiol 1991;17:999-1006.)]TJ
-2.1381 -1.25 Td
[(1)36.9 (1.)-875 (Brennan P)110.8 (, Silman )54.8 (A, Black C, et al. Reliability of skin)]TJ
2.1381 -1.25 Td
[(involvement measures in scleroderma. )17.7 (The UK Scleroderma Study)]TJ
T*
(Group. Br J Rheumatol 1992;31:457-60.)Tj
-2.175 -1.25 Td
[(12.)-875 (Clements P)110.8 (, Lanchenbruch P)110.8 (, Siebold J, et al. Inter and)]TJ
2.175 -1.25 Td
[(intraobserver variability of total skin score \(Modified Rodnan )17.8 (TSS\))]TJ
T*
(in systemic sclerosis. J Rheumatol 1995;22:1281-5.)Tj
-2.175 -1.25 Td
[(13.)-875 (White B, Bauer EA, Goldsmith LA, et al. Guidelines of clinical)]TJ
-0.00011 Tc 2.175 -1.25 Td
[(trials in systemic sclerosis \(Scleroderma\). )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1995;38:351-60.)Tj
0.02499 Tw -2.175 -1.25 Td
[(14.)-875 (Ferri C, Bernini L, Bongiorni MG, et al. Non invasive evaluation of)]TJ
2.175 -1.25 Td
(cardiac dysrhythmias and their relationship with multisystemic)Tj
-0.00011 Tc T*
[(symptoms in progressive sclerosis patients. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1985;28:1259-66.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(15.)-875.1 (Roberts NK, Cabeen )17.7 (WR Jr)39.7 (, Moss J, Clements PJ, Furst DE. )17.7 (The)]TJ
0 Tc 2.175 -1.25 Td
(prevalence of conduction defects and cardiac arrhythmias in)Tj
-0.00011 Tc T*
[(progressive systemic sclerosis. )54.8 (Ann Intern Med 1981:94;38-40.)]TJ
-2.175 -1.25 Td
[(16.)-875.1 (Rokas S, Mavrikakis M, )54.8 (Agrios N, Mylonas D, )54.8 (Antoniadou L,)]TJ
0 Tc 2.175 -1.25 Td
(Moulopoulos S,. Electrophysiologic abnormalities of cardiac)Tj
-0.00011 Tc T*
(function in progressive systemic sclerosis. J Electrocardiol)Tj
0 Tc 0 Tw T*
(1996;29:17-25.)Tj
0.02499 Tw -2.175 -1.25 Td
[(17.)-875 (Hombach )17.8 (V)129.1 (. )17.8 (The high resolution electrocardiogram: clinical)]TJ
-0.00011 Tc 2.175 -1.25 Td
[(aspects. In: El-Sherif N, )17.7 (T)34.8 (uritto G, eds. High-resolution)]TJ
0 Tc T*
[(electrocardiography)64.9 (. New )36.8 (Y)100.1 (ork: Futura Publishing Company)64.9 (, Inc.)]TJ
0 Tw T*
[(1992:21)36.9 (1-41.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(18.)-875.1 (Gardner PI, Ursell PC, Pham )17.7 (TD, Fenoglio JJ, )17.7 (W)39.7 (itt )54.8 (AL.)]TJ
0 Tc 2.175 -1.25 Td
(Electrophysiologic and anatomic basis for fractionated electrograms)Tj
33 36.25 Td
(recorded from healed myocardial infarcts. Circulation 1985;)Tj
0 Tw T*
[(72:596-61)36.9 (1.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(19.)-875.1 (Mehta D, McKenna )17.7 (WJ, )17.7 (W)79.7 (ard DE, Davies MJ, Camm )54.8 (AJ.)]TJ
0 Tc 2.175 -1.25 Td
(Significance of signal-averaged electrocardiography in relation to)Tj
T*
(endomyocardial biopsy and ventricular stimulation studies in)Tj
T*
(patients with ventricular tachycardia without clinically apparent)Tj
T*
[(heart disease. J )54.8 (Am Coll Cardiol 1989;14:372-9.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(20.)-875.1 (Morelli S, Sgreccia )54.8 (A, De Marzio P)110.7 (,)-0.1 ( et al. Noninvasive assessment)]TJ
0 Tc 2.175 -1.25 Td
(of myocardial involvement in patients with systemic sclerosis: role)Tj
T*
[(of signal averaged electrocardiography)64.9 (. J Rheumatol 1997;)]TJ
0 Tw T*
(24:2358-63.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(21.)-875.1 (Janosik DL, Osborn GT)73.9 (, Moore )17.7 (TL, Shah DG, Kenney RG,)]TJ
2.175 -1.25 Td
[(Zuckner J. Heart disease in systemic sclerosis. Semin )54.8 (Arthritis)]TJ
0 Tc T*
(Rheum 1989;19:191-200.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(22.)-875.1 (LeRoy EC. )17.7 (The heart in systemic sclerosis. N Engl J Med)]TJ
0 Tc 0 Tw 2.175 -1.25 Td
(1984;310:188-90.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(23.)-875.1 (Kuwana M, Kaburaki J, Okano )36.8 (Y)129 (,)-0.1 ( )17.7 (T)69.7 (ojo )17.7 (T)73.9 (,)-0.1 ( Homma M. Clinical and)]TJ
0 Tc 2.175 -1.25 Td
(prognostic associations based on serum antinuclear antibodies in)Tj
-0.00011 Tc T*
[(Japanese patients with systemic sclerosis . )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1994;37:75-83.)Tj
0.02499 Tw -2.175 -1.25 Td
[(24.)-875 (Black CM. Measurement of skin involvement in scleroderma. )]TJ
2.175 -1.25 Td
(J Rheumatol 1995;22:1217-9.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(25.)-875.1 (Steen )17.7 (VD, Medsger )17.7 (T)79.7 (A, Jr)54.8 (. Severe or)17.7 (gan involvement in systemic)]TJ
2.175 -1.25 Td
[(sclerosis with dif)17.7 (fuse scleroderma. )54.8 (Arthritis Rheum 2000;)]TJ
0 Tc 0 Tw T*
(43:2437-44.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(26.)-875.1 (Clements PJ, Lachenbruch P)91.7 (A, Furst DE, Paulus HE, Sterz MG.)]TJ
0 Tc 2.175 -1.25 Td
(Cardiac score: a semiquantitative measure of cardiac involvement)Tj
-0.00011 Tc T*
(that improves prediction of prognosis in systemic sclerosis .)Tj
0 Tc T*
(Arthritis Rheum 1991;34:1371-80.)Tj
ET
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2002. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
75 0 obj
<>
endobj
91 0 obj
<>
endobj
37 0 obj
<>
endobj
41 0 obj
<>
endobj
42 0 obj
<>
endobj
63 0 obj
<>stream
HtV
PT}owY 5
>1X@T*.j*8Еq jƚT^d@M$6uU'j~j},V;{ιg.X
ff?_DԪH~w^@$7x~Pk#ʷyrFUw}kBZb+h\#
+;u/nq]UKW$ۀ:, EjFlA}ݲgA^5,*A%玕o ~/wNЖ7Ў/F*
P(u{ܱY1q;y# ƬEȒ
V
yN%1*D8aDPS9؈&~'j[w[aA-me5gn>8e
,gGR*nbfh#]'k>bwD+ى42OybD8%~1zYƱ2濌n6uI
λ!:y[Zz7@<_Jz
X"݊wq]}K$$&.%d9>fUK(t4E_^Z۬^gb4)gtD%xx9\E|HcE+V_JJ(yP$:yNKRL-Wmh/;K?wB*Z]}&z*vXNfe6N'a2r{ݬf;wQ7}>>$9b'
E(弟9BDhkz[cmqTgyUqtHL"}4U2,ɈLzM6ٮA+J:sy73/KG#11ۙ\B]_n0>6sbw4*?B:\z5gjgǠjwYmks1EhKr5Բ)*>1Pm]'do(V?WԌuXw~qFq\-9O0vڣ3V:#v6WPGtso
3aEy-b=!};[S[NQ5'jFϞ]֡owg\N(Wj5;fLN7W3Kp\.CŞr+-uczD⮯2mq-NEQi_DWq_Z)I
JZ^%/Q^'qSGK-uѢIjxv2j2[ˡ6Zeljٶ.8qML3IH?4>9ئ+~{ߋqy v!ωM " Mm RR(vWFdLcʨPd`IT"uڴ4Ȥ4h켗ЮRd{w}B1ӌ"=K+Ȇ> ɗFf#l%_C- <'I,hZBB-d~@E0-I*&ۋIw1[Sp $ :Fޏ7cdO#OLj=F9dV!ڃZՐ=?WV2/(J:ŻQÈvJQD[W[W_H%Э+|tp,H3i0K'ڹpO@VsK巸A`'\vLkE:sy :Y8e{3}÷rcZdXP(P魯OyPoqõ0wT.u8
QAŝ_}/|/;Jn<"mTܳ8
ZS^-/sMҩHMI-/Iy(V.x[{
^ᑆ.`x\i9 $rOST1^1+cb
հjVɲ0oYSfPK
:Q)dI:JF,S+'$P~4FfӲl˚<_2yƺ*Y!LZWœUb!uF#=Qg;<*#VǓ[Vf N{ ē+$?"QBT
Lـd7eƃ0J4FdSÒ-,[JJ$J&rh bKV$Jʤ*9$MR~0H+$.[V nLǧ Ϙڎ+gxߵfK>6]:֮[/5cHr3bK
p3BԠI mRA<Գoc{q6z3QcEXQ1V#ݰk͛ۻjX8j8O&PdLrYMS9
#sؚ_VdyvnY7QBQ>_oowgy$?z/C<^_)<ȁjBҪr5!jZUTF4u<0M&Ga)(Z>Vja/|ЂQYosXtC-%#yd|D76,C#B
5[ k(
1ϋyՁj?vb
v:.lkWU%#CUrMy+!;2'ʻTִ_CnU|77TZkf?SO_np#?̬
:0Y=&G